Anesthesia progress
-
Anesthesia progress · Jan 1994
Case ReportsTENS-induced pain control in a malignant hyperthermia-susceptible patient.
Malignant hyperthermia (MH) is a severe and often fatal disease that is triggered by exposure to the neuromuscular blocking drug succinylcholine and/or volatile general anesthetics (eg, halothane). Although all local anesthetics are now considered to be safe in malignant hyperthermia patients, some individuals still prefer not to use amide-type anesthetics. Here we report a case of a MH-susceptible patient who successfully received restorative dental treatment with transcutaneous electrical nerve stimulation. We suggest that this may be a safe alternative to consider in patients who have an aversion to chemical anesthetic agents.
-
Anesthesia progress · Jan 1994
Randomized Controlled Trial Comparative Study Clinical TrialEffective postoperative pain prevention through administration of bupivacaine and diclofenac.
The efficacies of bupivacaine and lidocaine together with a preoperatively administered single-dose oral combination of normal- and sustained-release preparations of diclofenac in preventing postoperative pain after third molar removal were compared in a double-blind crossover study. Bilaterally impacted lower third molars were removed in two sessions. Each patient was given one type of local anesthetic on one session and the other in the second. ⋯ When the diclofenac combination (150 mg) was given before the operation, postoperative analgesia was better with bupivacaine plus diclofenac than with lidocaine plus diclofenac. Twenty-five out of 40 patients preferred bupivacaine to lidocaine for local anesthesia. It is possible to achieve effective postoperative pain prevention by combining bupivacaine and preoperative normal- and sustained-release preparations of diclofenac.
-
Anesthesia progress · Jan 1993
Randomized Controlled Trial Comparative Study Clinical TrialThe safety and efficacy of outpatient midazolam intravenous sedation for oral surgery with and without fentanyl.
This study examined midazolam and midazolam plus fentanyl in a placebo-controlled, double-blind clinical trial. It tested the hypothesis that combined drug therapy results in significantly poorer safety but no difference in efficacy compared to the single drug approach. Subjects were among 207 mildly anxious young adults having their third molars removed. ⋯ About twice as many subjects in the combination group had end-tidal carbon dioxide (EtCO2) levels greater than 25% above baseline. While these results are consistent with those for apnea, contingency analyses of the oxygen saturation and EtCO2 results were not statistically significant. Subjects in the combination group were more than four times as likely to have excellent versus good, fair, or poor sedation at a given level of intraoperative pain, and behavioral (movement and verbalization) but not cognitive measures of anxiety were attenuated.
-
This article presents a different method of venous cannulation. It has been used successfully to teach dental residents working on pediatric and developmentally disabled patients. The technique includes using a syringe of 1% lidocaine hydrochloride attached to a 25-ga needle to produce a skin wheal by "jet injection." This is accomplished by placing the bevel of the needle downward and forcing the syringe in a downward and backward direction, with pressure being continuously exerted on the plunger. ⋯ The catheter is bent, with its bevel up, approximately three-fourths of the way from the tip to form a gradually sloping bend of approximately 40 degrees to 45 degrees. The catheter is then inserted into the skin wheal and advanced into the vein. The advantages of this technique are that it (1) can eliminate the pain associated with a subcutaneous infiltration of a local anesthetic solution, (2) provides a method of venous cannulation that is easier to master by the novice, and (3) gives a visual check on successful catheterization of the vein.
-
Anesthesia progress · Jan 1993
Case ReportsTotal intravenous anesthesia with propofol for thymectomy in a patient with myasthenia gravis.
Experience with the use of propofol for induction and maintenance of anesthesia in patients with myasthenia gravis is limited. This case report documents the safe use of propofol in a patient with myasthenia gravis. Because of its unique pharmacodynamic and pharmacokinetic profile, propofol may be an ideal agent for safe use in the young patient with myasthenia gravis.